These observations are consistent with the view that mutations associated with genetic forms of human prion disease that affect the stability and biochemistry of PrP [15–19,22,24] or its ability to transit the secretory pathway [22,24,60,69] are manifest in the prion protein when expressed in Drosophila. The gene discussed is PRNP; the disease is prion disease.